Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

290 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Recruiting

Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

NCT06414954

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Profound Research LLC Carlsbad, California, United States
  • University of California Irvine Medical Center Irvine, California, United States
  • University of Colorado Neuromuscular Division Aurora, Colorado, United States
  • SFM Clinical Research, LLC Boca Raton, Florida, United States
View all 40 locations
View Trial Details
Recruiting

A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases

NCT07304154

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +22 more
Locations
  • Stanford Neuroscience Health Center Palo Alto, California, United States
  • Columbia University Irving Medical Center New York, United States
  • LDS Hospital - Intermountain Health Salt Lake City, Utah, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
View Trial Details
Recruiting

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

NCT06704269

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Wake Forest Univ School of Medicine Winston-Salem, North Carolina, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Houston Methodist Hospital Houston, Texas, United States
View Trial Details
Recruiting

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

NCT06517758

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • SC3 Research Pasadena Pasadena, California, United States
  • California Pacific Medical Center Sacramento, California, United States
View all 125 locations
View Trial Details
Recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

NCT06456580

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 111 locations
View Trial Details
Recruiting

A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

NCT06392386

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Carolinas HealthCare System Neurosciences Institute - Neurology Charlotte, North Carolina, United States
  • Neurology Rare Disease Center Denton, Texas, United States
  • University of Virginia Charlottesville, Virginia, United States
  • UZ Gent Ghent, Belgium
View all 20 locations
View Trial Details

Related conditions